Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Janhofer Guenter — Quince Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Janhofer Guenter

Janhofer Guenter

Chief Scientific Officer at Quince Therapeutics, Inc. · on record since Oct 24, 2023

Insider trading activity of Janhofer Guenter

Transactions on record: 1; since Oct 24, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Oct 24, 2023

Figures computed from official regulatory filings — methodology.

Companies where Janhofer Guenter has traded

Quince Therapeutics, Inc.1 tx · Oct 24, 2023

Track record of Janhofer Guenter

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Janhofer Guenter

Co-insiders of Janhofer Guenter

Bray JuneQuince Therapeutics, Inc.
Hannah BrendanQuince Therapeutics, Inc.
Lamond DavidQuince Therapeutics, Inc.
Luca BenattiQuince Therapeutics, Inc.
McLoughlin MargaretQuince Therapeutics, Inc.
Monohon TedQuince Therapeutics, Inc.
Patni RajivQuince Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Roberts BrigetteQuince Therapeutics, Inc.

Ryan Charles S.Quince Therapeutics, Inc.

RYAN UNA SQuince Therapeutics, Inc.

Senner Christopher J.Quince Therapeutics, Inc.

Smith Karen L.Quince Therapeutics, Inc.

Thye DirkQuince Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Quince Therapeutics, Inc.	Oct 24, 2023	AwardD	300,000	0.00 USD	$0	SEC